Transcriptomics

Dataset Information

0

Nicotinamide Mononucleotide alleviates aging defects of Hutchinson-Gilford progeria syndrome


ABSTRACT: Hutchinson-Gilford Progeria Syndrome (HGPS) is a rare genetic disorder characterized by mutations in the LMNA gene, resulting in progerin accumulation and accelerated aging, with limited therapeutic options currently available. This study demonstrates the significant therapeutic potential of nicotinamide mononucleotide (NMN) in alleviating HGPS phenotypes at both cellular and organismal levels. Using patient-derived induced pluripotent stem cell-mesenchymal stem cells (iPSC-MSCs), we demonstrated that enhancing NAD+ biosynthesis through NMN supplementation effectively restored mitochondrial function, reduced DNA damage and inflammatory markers, and mitigated oxidative stress. Furthermore, in G608G transgenic mouse models receiving NMN administration over four months, we observed significant improvements in fertility and gonadal function, enhanced cardiovascular parameters, ameliorated skin pathology, and extended lifespan. These comprehensive findings establish NMN supplementation as a promising therapeutic strategy for HGPS and potentially other aging-related disorders.

ORGANISM(S): Homo sapiens

PROVIDER: GSE295355 | GEO | 2025/08/01

REPOSITORIES: GEO

Dataset's files

Source:
Action DRS
Other
Items per page:
1 - 1 of 1

Similar Datasets

2011-03-14 | E-GEOD-24487 | biostudies-arrayexpress
2011-03-14 | GSE24487 | GEO
2024-10-17 | E-MTAB-13678 | biostudies-arrayexpress
2019-09-10 | GSE137084 | GEO
2019-09-10 | GSE137083 | GEO
2020-01-02 | GSE84351 | GEO
2020-01-02 | GSE84356 | GEO
2012-10-30 | E-GEOD-41757 | biostudies-arrayexpress
2012-10-30 | E-GEOD-41763 | biostudies-arrayexpress
2012-10-30 | GSE41751 | GEO